Water-in-oil emulsion metal oxide based sunscreen formulations

The use of electrosteric polymeric dispersing agents in water-in-oil emulsion sunscreen formulations stabilizes metal oxide particles, enhancing SPF efficiency and skin feel while minimizing skin whitening, addressing the agglomeration issues in conventional metal oxide sunscreens.

WO2024233498A1PCT designated stage expired Publication Date: 2024-11-14NANOMATERIALES QUÍMICOS AVANZADOS SA DE CV +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/028048
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-05
Filing Date
2024-05-06
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Conventional metal oxide sunscreen formulations suffer from decreased SPF efficiency over time due to agglomeration of metal oxide particles, leading to reduced skin feel and increased skin whitening, while chemical sunscreens have detrimental health and environmental impacts.

Method used

The development of water-in-oil emulsion sunscreen formulations that utilize electrosteric polymeric dispersing agents to maintain metal oxide particles as small aggregates and agglomerates in the range of 100 nm to 150 nm, providing stable and high SPF efficiency with reduced skin whitening and improved skin feel.

Benefits of technology

The formulations achieve higher SPF efficiency and stability with lower metal oxide concentrations, reducing skin whitening and enhancing skin feel by maintaining metal oxide particles in a stable, small aggregate form, thus addressing the limitations of conventional formulations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 000001
    Figure 000001
  • Figure 000002
    Figure 000002
  • Figure 000003
    Figure 000003
Patent Text Reader

Abstract

Described herein are water-in-oil metal oxide based sunscreen formulations including an electrosteric polymeric dispersing agent that disperses the metal oxide in the water phase of the water-in-oil emulsion, where the sunscreen formulations have high SPF efficiencies, reduced skin whitening, and improved skin feel over conventional metal oxide sunscreens.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] WATER-IN-OIL EMULSION METAL OXIDE BASED SUNSCREEN FORMULATIONS

[0002] CROSS-REFERENCE TO RELATED APPLICATIONS

[0003] The present application claims the benefit of and priority to U.S. Provisional Application No. 63 / 464,261, filed May 5, 2023, which is hereby incorporated by reference in its entirety for all purposes.

[0004] FIELD

[0005] The present disclosure relates to metal oxide based sunscreen formulations where the metal oxide is dispersed in the water phase of a water-in-oil emulsion.

[0006] BACKGROUND

[0007] Sunscreens are available in a variety of formulations and with a variety of active ingredients. Chemical sunscreens include active ingredients which are organic molecules that absorb UV rays. Mineral sunscreens (also called physical sunscreens) include active ingredients that are inorganic compounds, typically metal oxides such as zinc oxide and / or titanium dioxide. Those ingredients provide a physical barrier that absorbs UV rays and also scatters, i.e., reflects and refracts, UV rays.

[0008] Chemical sunscreens have long been preferred by consumers because they absorb into skin, which allows them to be less visible on skin compared to mineral sunscreens. Chemical sunscreens also work well under makeup and feel better on skin than mineral sunscreens. But it has been determined that chemical sunscreens can have detrimental effects on the health of the wearer as well as on the environment. Some chemical sunscreens have even been banned in certain areas due to their negative impact on aquatic life.

[0009] The mineral sunscreen active ingredients zinc oxide and titanium dioxide are generally recognized as safe and effective (GRASE) by the U.S. Food and Drug Administration. In feet, metal oxides are commonly used as pigments in cosmetics, where they are used to blend colors to smooth skin tones and cover blemishes. Consumers, however, often object to metal oxide sunscreens that cause skin to appear white. Some consumers also object to the feel of tire metal oxides on skin.

[0010] 1 Another problem with metal oxides sunscreen formulations is that the SPF provided by the formulation can decrease over time due to agglomeration of metal oxide particles. Metal oxides exist in formulations as aggregates of primary particles. Those aggregates cluster together to form larger agglomerates. Larger metal oxide units have lower surface areas, which leads to lower SPF efficiencies (SPF value per 1% metal oxide). Thus, when metal oxide particles and aggregates form larger agglomerates, the SPF value of the formulation decreases.

[0011] There is a need for improved metal oxide sunscreen formulations that have improved skin feel, reduced skin whitening, and high SPF efficiencies that are stable over time.

[0012] SUMMARY

[0013] Disclosed herein are metal oxide based sunscreens that have improved skin feel, reduced skin whitening, and high SPF efficiencies that are stable over time. The sunscreen formulations are water-in-oil emulsions that include a metal oxide and an electrosteric polymeric dispersing agent that disperses the metal oxide in the water phase of the emulsion as very small aggregates and agglomerates. The small size of the dispersed metal oxide aggregates and agglomerates provides formulations with high SPF efficiencies that are stable over time, improved skin feel, and reduced skin whitening.

[0014] DETAILED DESCRIPTION

[0015] Provided herein are metal oxide based sunscreen formulations where the metal oxide is present in the water phase of a water-in-oil emulsion. The metal oxides are dispersed and stabilized in the water phase, which itself is dispersed in the continuous oil phase of die emulsion. The formulations include an electrosteric polymeric dispersing agent that is a charged polymer with side chains with at least 3 carbon atoms. The charge on the dispersing agent provides electrostatic repulsion and the alkyl groups provide steric stabilization. That combination of properties allows the dispersing agent to maintain the metal oxide particles in the water phase as agglomerates having a very small size in the range of 100 nm to 150 nm. The small size of the dispersed metal oxide agglomerates results in a stable formulation with a significantly higher SPF efficiency than achieved by conventional formulations, so a lower amount of metal oxide is required to achieve a desired SPF. The small size of the dispersed

[0016] 2 metal oxide agglomerates also leads to reduced skin whitening compared to prior art formulations with similar SPF.

[0017] Metal oxides useful in the formulations are UV attenuation grade metal oxides, which are suitable for UV absorption, and specifically for UVB absorption. Attenuation grade metal oxides have a primary particle size of less than 200 nm, and metal oxides effective for absorbing UV typically have primary particle sizes less than 100 nm. In some embodiments, the metal oxides used in the inventive formulations have an average primary particle size in a range of from about 20 nm to about 25 nm. In formulations, however, the metal oxides do not exist as primary particles but are always clustered together as aggregates or agglomerates. Aggregates are clusters of primary particles that cannot be broken up except by energy intensive mechanical means, such as ball milling. Aggregates typically include a small number of primary particles such as about 6 to 8 primary particles.

[0018] Aggregates can cluster together to form larger agglomerates, but agglomeration is undesirable because smaller units have advantages properties for the inventive formulations. The agglomerate size of a metal oxide determines end use properties of the formulation. For example, metal oxide formulations with larger agglomerate sizes will whiten skin more than formulations with smaller sizes. Smaller metal oxide agglomerates provide better SPF efficiency and dispersions of smaller agglomerates are stable over longer periods of time compared to dispersions of larger agglomerates.

[0019] Agglomeration can be minimized by use of an appropriate dispersing agent. In cosmetic formulations, it is known to disperse metal oxides using dispersing agents such as phospholipids and diols. But cosmetic grade pigments have primary particle sizes larger than UV attenuation grade metal oxides, greater than 200 nm. Thus, the metal oxide agglomerates in cosmetic formulations are significantly larger than what would be effective in a sunscreen formulation. Because the beneficial properties provided by the inventive sunscreen formulations depend on maintaining the metal oxides as very small aggregates / agglomerates, dispersing agents known for use with cosmetic grade are not suitable for use in the inventive formulations. Thus, in some embodiments the formulations described herein do not include phospholipid or diol dispersing agents.

[0020] The dispersing agents disclosed herein are especially effective at dispersing UV attenuation grade metal oxides having very small primary particle sizes. Such effective dispersion provides metal oxide agglomerates with very small sizes. In the sunscreen

[0021] 3 formulations described herein, the dispersed metal oxide agglomerates have an average size ranging from about 5 nm to about 250 nm, from about 75 nm to about 200 nm, about 100 nm to about 150 nm, about 100 nm to about 130 nm, or from about 75 nm to about 150 nm. Particle size is measured using laser diffraction methodology. Without the dispersing agents, the agglomerate size of pigmentary grade zinc oxide is from 1000 nm to 1500 nm. The small size of the dispersed metal oxide agglomerates provides higher SPF efficiency, enhanced stability, and reduced skin whitening compared to prior art formulations. For example, the inventive formulations have an SPF efficiency greater than 8 to 1.

[0022] Dispersing agents useful in the formulations disclosed herein are electrosteric polymeric dispersing agents that are water soluble or water dispersible. The dispersing agents are charged polymers with side chains that include at least 3 carbon atoms. The polymers are non-linear and are not crosslinked. The charged polymer backbone provides electrostatic stabilization and the polymeric side chains provide steric stabilization. The combination of both stabilization mechanisms is electrosteric stabilization.

[0023] Dispersants are materials which help separate particles in a formulation and reduce settling / agglomeration of the particles. They can be surfactants or polymeric materials. The mechanism of dispersing includes wetting the surface of the dispersed particle / agglomerate, mechanical action leading to agglomerate size reduction, and stabilization of separated particles to prevent reagglomeration. Efficiency of wetting depends primarily on the comparative surface tension properties of the pigment and the vehicle, as well as the viscosity of the resultant mix. A good dispersant can displace gases, liquids, and other contaminants from a pigment surface increasing the surface area available for wetting and reducing the need for mechanical energy.

[0024] The electrosteric polymeric dispersing agents used herein are especially effective at dispersing the metal oxides. The dispersant adsorption mechanism depends on the chemical nature of the pigment and the types of dispersing agents used. The charged polymeric structure of die dispersing agent provides electrostatic stabilization through multiple anchoring points between the dispersing agent and the metal oxide particles. Those multiple anchoring points lead to excellent adsorption of the dispersing agent on the surface of the pigment particles. Also, when mechanical action is used to break up larger agglomerates, the charged polymeric structure facilitates quick wetting of the new particle surface to prevent agglomerates from reforming.

[0025] 4 In some embodiments, the charge on the polymer is due to an acidic or amino group in the side chain. Thus, in some embodiments, the electrosteric polymeric dispersing agent is a polymer or copolymer that includes at least one monomer type that provides an acidic or amino group in the side chain. As one example, the acidic side chain can be provided by an acrylate, maleic acid, or maleic anhydride. Thus, in some embodiments, the electrosteric polymeric dispersing agent is a polymer or copolymer that includes acylate, maleic acid, or maleic anhydride monomers.

[0026] The electrosteric polymeric dispersing agents provide entropic (steric) stabilization through sterically bulky side chains. The side chains include at least three carbon atoms. In some embodiments, the side chains include more than three carbon atoms, such as at least four, at least five, at least six, at least seven, or at least eight carbon atoms. In some examples, the side chain includes a branched alkyl group. Optionally, the side chains include heteroatoms. The side chains provide a large steric barrier (70-120 A) that facilitates dispersion and inhibits reagglomeration of dispersed aggregates. Thus, the dispersant keeps pigment particles separated by adsorbing onto the pigment particle and inhibiting particle reagglomeration. Thus, the formulations remain stable for long periods of time.

[0027] In some embodiments, the dispersing agent is a polymer or copolymer including a- substituted acrylate or methacrylate monomers, and the sterically bulky side chain is the a- substitution of the acrylate or methacrylate monomer. In some embodiments, the dispersing agent is a copolymer of acrylic monomers and a-substituted methacrylate monomers, where the a-substitution includes more than three carbon atoms. Optionally, the a-substitution further includes one or more heteroatoms, such as oxygen, nitrogen, or phosphorus. In some embodiments, the a-substitution is a branched alkyl group including at least six carbon atoms, at least seven carbon atoms, or at least eight carbon atoms. As non-limiting examples, in some embodiments the acrylate or methacrylate monomer is a methacryloyloxyethyl phosphate, ethylhexylacrylate, dimethylaminoethyl methacrylate, or a butyl ester of PVM / MA copolymer.

[0028] Specific non-limiting examples of polymeric electrosteric dispersing agents that are useful in the disclosed formulations include, but are not limited to, acrylate / methacryloyloxyethyl phosphate copolymer (available from Dow as Soltex INO Polymer), acrylate / ethylhexylacrylate copolymer (available from Daito Kasei Kogyo Co. as Daitosol 4000SJT), acrylate / dimethylaminoethyl methacrylate copolymer (available from

[0029] 5 Zschimmer & Schwarz as SYNTRAN® 5778), butyl ester of PVM / MA copolymer (Gantrez A425-Ashland Chemical).

[0030] In comparison to the dispersants used in the formulations described here, conventional sunscreen dispersants are monomeric or oligomeric, having low molecular weights and often containing no more than 18 carbons. Those dispersants have fewer anchoring groups per molecule and poor adsorption on die surface of metal oxide aggregates and agglomerates. The smaller dispersant molecules also have a lower steric barrier, about 20 A to 22 A, which is not as effective at dispersing or at preventing reagglomeration as the polymeric electrosteric dispersants used in the inventive formulations.

[0031] In some embodiments, the formulations include the electrosteric polymeric dispersing agent in a concentration from 0.2 % to 10 % by weight, such as from 0.2 % to 5 %, 0.2 % to 3 %, 0.2 % to 2 %, 0.3 % to 2 %, 0.5 % to 2 %, 0.3 % to 1 %, or 0.3 % to 0.7 % by weight In some examples, the formulations include the electrosteric polymeric dispersing agent in a concentration of less than 10 % by weight, less than 5 %, less than 3 %, less than 2 %, or less than 1 % by weight.

[0032] As explained above, the metal oxides are present in the formulation in the form of agglomerates and aggregated primary particles, and the electrosteric polymeric dispersing agent enables stabilization of very small agglomerates. In some embodiments, the metal oxides have an average primary particle size in the range of 20 nm to 25 nm. In some embodiments, the agglomerates of the primary particles have an average size ranging from about 5 nm to about 250 nm, from about 75 nm to about 200 nm, about 100 nm to about 150 nm, about 100 nm to about 130 nm, or from about 75 nm to about 150 nm.

[0033] Metal oxides useful in the formulations include, but are not limited to, zinc oxide, titanium dioxide, cerium oxide, and iron oxide. Combinations of metal oxides are also contemplated. In some embodiments, the metal oxide is zinc oxide, titanium dioxide, cerium oxide, iron oxide, or a combination thereof. In some embodiments, the metal oxide is zinc oxide. In some embodiments, the metal oxide is a combination of zinc oxide and titanium dioxide.

[0034] Examples of metal oxides that are useful in the disclosed formulations include, but are not limited to, uncoated zinc oxide powders, such as those commercially available as ZINCLEAR® XP (available from Antaria) and Z-COTE® (available from BASF), and uncoated zinc oxide powder dispersions, such as commercially available as SunPrep IMZ60

[0035] 6 (60 % dispersion, available from NanoQem). Other metal oxides that are useful in the disclosed formulations include, but are not limited to, inorganic coated titanium dioxide powders, such as those commercially available as MT05 (available from Tayca) and Solaveil XTP-2 (available from Croda).

[0036] The formulations disclosed herein provide effective UVB protection with lower concentrations of metal oxides than in conventional sunscreens. In some embodiments, the formulations include the metal oxide in concentrations of from 3 % to 25 % by weight, such as from 3 % to 20 %, from 3 % to 15 %, from 3 % to 10 %, or from 3 % to 7 % by weight. In some examples, the formulations include the metal oxide in concentrations of less than 20 % by weight, less than 18 %, less than 16 %, less than 12 %, or less than 10 % by weight.

[0037] The formulations disclosed herein include water, the electrosteric polymeric dispersing agent, metal oxide, and optionally include various other ingredients. Unless otherwise stated, any of the formulations described herein optionally further includes one or more of one or more emollients, humectants, skin soothing aids, skin repair actives, neutralizing agents, organic sunscreens, emulsifiers, preservatives, SPF boosters, or emulsion stabilizers.

[0038] Emollients useful in the formulations disclosed herein are natural and synthetic emollients, including but not limited to, C12-15 alcohol benzoate, coco caprylate, capric / caprylic triglyceride, trisiloxane, dicaprylyl carbonate, ethyl hexyl isononanoate, isononyl isononanoate, tridecyl salicylate (available as Dermol™ TDS from Alzo), butyloctyl salicylate (available as HALLBRITE® BHB from Hallstar), and combinations thereof. The emollient or combination thereof is present in the formulation at a concentration of up to 40 % by weight, such as from 10 % to 40 % by weight

[0039] The emulsifier in the inventive formulations is not particularly limited and can be any useful emulsifier or combination thereof known in the art. In some embodiments, the emulsifier is a polymeric emulsifier. As non-limiting examples, emulsifiers useful in the formulations disclosed herein include, but are not limited to, PEG-30 dipolyhydroxystearate (available as Cithrol DPHS from Croda), polyglyceryl-2 dipolyhydroxystearate (available as Dehymuls PGPH from Evonik), tri(polyglyceryl-3 / lauryl) hydrogenated trilinoleate (available as Cithrol PGTL from Croda), polyglyceryl-4 diisostearate polyhydroxystearate / sebacate (available as Isolan GPS from Evonik), diisostearoyl polyglyceryl-3 dimer dilinoleate (available as Isolan PDI from Evonik), polyglyceryl-2 dipolyhydroxystearate (available as

[0040] 7 Dehymuls PGPH fiom BASF). Combinations of flic fixgoing are also useful, such as polyglyceryl-4 diisostearate / pdyhydroxystearatc / sdxKatc and caprylic / capric triglyceride and polyglyccryl-3 oleate and diisostearoyl polyglyccryl-3 dimer dilinoleate (available as Isolan H fiomEvonik). The emulsifier or combination thereof is present in the formulation at a concentration of up to 5 % by weight, such as fiom 2 % to 5 % by weight

[0041] The formulations disclosed herein optionally include an SPF booster. The SPF booster is not particularly limited and can be any usefill SPF booster or combination thereof known in die art As non-limiting examples, SPF boosters useful in the fixmulations disclosed herein include, but are not limited to, cthylhcxyl mcthoxycrylenc (available as Solastay S-l from HallStar), poly Cioao alkyl acrylate (available as Tego SP13-6 from Evonik), diethylhexyl 2,6-naphthalate (available as Corapan TQ from Symrise), trimcthoxybcnzylidenc pentanedione (available as Synoxyl HSS fiom SytheonX styrcnc / acrylates copolymer (available as SunSpherea, 90% active powder, fiom Dow Chemical), VP / eicosene copolymer (available as Gansx / Antaron 220 fiom Ashland), and combinations thereof. When present, die SPF booster or combination thereof is present in die formulation at a concentration of up to 20% by weight such as fiom 3 % to 20 % by weight

[0042] In embodiments of die inventive formulations other optional ingredients, when present can be present in any useful amount In some embodiments, certain optional ingredients, when present can be present in die formulation in the following concentrations: humectant up to 5 % by weight, such as from 1 %to 5 %by weight skin soothing aids up to 2 % by weight, such as from 0.2 % to 2 % by weight; skin repair actives up to 3 % by weight, such as fiom 02 % to 3 % by weight; preservative up to 1.5 % by weight such as fiom 0.5 % to 1.5 % by weight; emulsion stabilizer up to 3 % by weight, such as from 1 % to 3 % by weight

[0043] The metal oxide sunscreen fixmulations described herein are water-in-oil emulsions that include an aqueous phase dispersed in a continuous hydrophobic phase, where die aqueous phase inchides die dectrosteric polymeric dispersant and dispersed metal oxide particles, hi some embodiments, the aqueous phase is fiom about 50 % to about 70 % by weight of die overall composition, but it could be more or less. In some embodiments, the aqueous phase is fiom about 55 % to about 65 % by weight of the overall compositions. The hydrophobic phase makes up die balance of the composition.

[0044] 8 In any embodiment, the formulation optionally includes the metal oxide in a concentration of from 3 % to 15 % by weight, from 3 % to 10 % by weight, less than 20 % by weight, less than 18 %, less than 16 %, less than 12 %, or less than 10 % by weight. In any embodiment, the formulation optionally includes the metal oxide in the form of agglomerates of aggregated primary particles, wherein the agglomerates have an average size from 100 nm to 150 nm, or from 100 nm to 130 nm. In any embodiment, the metal oxide includes zinc oxide, titanium dioxide, cerium oxide, iron oxide, or a combination thereof. In any embodiment, the metal oxide optionally is zinc oxide or zinc oxide in combination with titanium dioxide. In any embodiment, the formulation optionally further includes one or more of an emollient, humectant, organic sunscreen, emulsifier, SPF booster, emulsion stabilizer, or preservative.

[0045] In any embodiment, die formulation optionally includes the electrosteric polymeric dispersing agent in a concentration of from 0.2 % to 10 % by weight, such as from 0.2 % to 5 %, 0.2 % to 3 %, 0.2 % to 2 %, or 0.5 % to 2 % by weight, or in a concentration of less than 10 %, less than 5 %, less than 3 %, or less than 2 % by weight. In any embodiment, the dispersing agent is a charged polymer comprising side chains comprising at least three carbon atoms, at least 4 carbon atoms, at least 5 carbon atoms, at least six carbon atoms, at least 7 carbon atoms, or at least 8 carbon atoms. In any embodiment, the polymer side chains optionally include a branched alkyl group. In any embodiment, die polymer side chains optionally further include at least one heteroatom selected from oxygen, nitrogen, or phosphorus. In any embodiment, the dispersing agent optionally includes an acrylate / ethylhexylacrylate copolymer, an acrylate / methacryloyloxyethyl phosphate copolymer, or an acrylate / dimethylaminoethyl methacrylate copolymer.

[0046] In some embodiments a metal oxide sunscreen formulation a metal oxide and an electrosteric polymeric dispersing agent, wherein the formulation is a water-in-oil emulsion, and wherein the metal oxide is present in the water phase of the water-in-oil emulsion, where the metal oxide is zinc oxide, the zinc oxide is present in the formulation at a concentration of from 5 % to 20 %, the dispersing agent is an acrylate / ethylhexylacrylate copolymer, and the acrylate / ethylhexylacrylate copolymer is present in the formulation at a concentration of from 0.5 % to 2.0 %.

[0047] The table below is not intended to be limiting but summarizes the type and amount of certain ingredients that may be present in some embodiments of the inventive formulations.

[0048] 9 Water-in-Oil Emulsion Metal Oxide Sunscreen

[0049] Carrier 30-70% (Deionized water) Humectant 1-5% (optional)

[0050] Skin Soothing Aids 0.2-2% (optional) Skin Repair Actives 0.2-3% (optional) Dispersing Agent 5-10% (based on the amount of metal oxide) Neutralizing Agent Optional, dependent on dispersant used Metal Oxide 3-15% (dependent on desired SPF) Organic sunscreens Optional Emollient 10-40% Emulsifier 2-5% (polymeric type) Preservative 0.5-1.5% SPF Boosters 3-20% Emulsion Stabilizer 1-3%

[0051] Methods for producing the metal oxide sunscreen formulations are also provided. In some embodiments, a metal oxide sunscreen formulation described herein can be formed by preparing an aqueous phase, preparing an oil phase, then combining and homogenizing the aqueous phase and the oily phase to form the water-in-oil emulsion. The aqueous phase can be formed by combining water and an electrosteric polymeric dispersing agent with a metal oxide and homogenizing the mixture. If other ingredients are desired in the aqueous phase, such as but not limited to humectants or pH adjusting agents, those ingredients are also added before homogenizing. As one non-limiting example, the homogenization of the aqueous phase can be accomplished with a roto / stator mill at 5,000 rms for 2 minutes. The oil phase is prepared by combining the hydrophobic ingredients, heating, and cooling. The ingredients may be combined at one time, or added at an appropriate time during the heating / cooling. Once the aqueous and oil phases are prepared, they are combined and homogenized. As one non-limiting example, die aqueous and oil phases can be homogenized using a roto / stator mill at 10,000 rpms for 2 minutes.

[0052] The combination of electrosteric polymeric dispersing agent and metal oxides described herein provides superior aqueous dispersing ability because the dispersing agent works by both electrostatic and steric stabilization mechanisms. Better dispersion and smaller particle sizes provide higher SPF efficiency (SPF units per 1% metal oxide used) As

[0053] 10 compared to conventional metal oxide sunscreen formulations, the higher SPF efficiencies of the inventive formulations allow effective sun protection with lower concentrations of metal oxide. Lower concentrations of metal oxides and reduced particle agglomeration due to better dispersion result in less skin whitening. The inventive formulations also provide better SPF stability over time due to the metal oxide particles exhibiting less agglomeration over time because of polymeric electrosteric stabilization. Also, since the metal oxides are in the emulsified water phase, there is less tendency for the metal oxides to settle out and agglomerate due to the emulsified phase yield value (zero shear viscosity of the formulation). Lower concentrations of metal oxides also has the benefit of reduced cost formulations.

[0054] When topically applied to skin, compared to conventional formulations, the inventive formulations provide inproved skin feel due to lower amounts of metal oxides as well as the fact that the metal oxides are encapsuled by the internal water phase of the emulsion. When rubbed on skin, the oil phase dominates the skin feel reducing the dry feel of the metal oxide.

[0055] Examples

[0056] The following examples are set forth to illustrate formulations and methods according to some embodiments disclosed herein. These examples are not intended to be inclusive of all aspects of the formulations and methods, but rather to illustrate representative formulations, methods, and results. These examples are not intended to exclude equivalents and variations of the subject matter described herein which are apparent to one skilled in the art.

[0057] In vitro SPF Comparison

[0058] Two sunscreens having the formulations listed below were prepared. Formulation 1 did not include polymeric electrosteric dispersant Formulation 2 included 1.5% acrylate / ethylhexylacrylate copolymer. To prepare the formulations, B (zinc oxide) was homogenized into A (aqueous phase) using a roto / stator mill at 5,000 rpms for 2 minutes. C (hydrophobic phase) was heated to 75° C and cooled to 60° C. When the batch temperature reached 45° C, D was added. Then AB was homogenized into CD using a roto / stator mill at 10,000 rpms for 2 minutes.

[0059] Formulation 1 2

[0060] A Deionized Water Carrier _ 55.0 50.5

[0061] Glycerin Humectant _ 2.0 2.0

[0062] Diatosol 4000 S JT Electrosteric Polymeric Dispersant 0 1.5

[0063] 1% Sodium Hydroxide Neutralizing Agent 0 0.5

[0064] 11 B ZinClearXP _ Zinc Oxide 6.0 6.0

[0065] C Butyloctyl Salicylate Emollient 10.0 10.0 Tridecyl Salicylate Emollient 5.0 5.0 Trisiloxane _ Emollient 5.0 5.0

[0066] SolaStay SP-1 _ SPF Booster 3.0 3.0

[0067] Ethylhexyl Isononanoate Emollient 10.0 10.0

[0068] Cithrol DPHS _ Emulsifier 3.0 3.0

[0069] Tego SP-1 _ SPF Booster 2.5 2.5

[0070] D Symdiol 68 Emollient 1.0 1.0

[0071] In vitro SPF: 127.5 154.5

[0072] For each formulation, SPF was measured in triplicate with a Labsphere UV2000S

[0073] SPF Analyzer using 25 mg of sample on a PMMA or collagen substrate (9 spots per plate).

[0074] All samples were mixed or shaken before application to assure uniformity. Plates were reweighed after application to confirm sample size, and samples were dried for 30 minutes prior to analysis. Using PMMA plates as a substrate can lead to low SPF results due to poor product spreading on plate, but excellent correlations with in vivo SPF results have previously been observed with similar formulations to the inventive examples.

[0075] As further non-limiting examples, the table below provides three specific examples of metal oxide sunscreen formulations.

[0076] These formulations were made by the same method described above.

[0077] Trade Name / Description Ingredient Purpose _ 1 2 3

[0078] A DI Water _ Water Carrier / Solvent 46.05 38.65 44.80

[0079] Glycerin 99% _ Glycerin Humectant 2.00 3.00 3.00

[0080] Daitosol 4000SJT - KOBO Aqua / Polymeric Acrylates / Ethylhexyl Electrosteric 1.50 1.50 1.50 Acrylate Copolymer Dispersant Skin repair

[0081] Niacinamide 1.00 1.00 active _

[0082] D-Panthenol 75% - BASF Skin soothing

[0083] Panthenol 1.00 aid _

[0084] 1.0% NaOH Solution Neutralizing

[0085] Sodium Hydroxide 0.50 1.00 0.50 Agent _

[0086] Micro HA Hyacross Skin repair Hyaluronic add - Bloomage Hyaluronic add active 0.20 0.20

[0087] B SunPrep IMZ60 - NanoQem 60% Zinc Oxide / water Metal Oxide 10.00 10.00 10.00 / xanthan gum

[0088] C EHIN - Chemspire Ethylhexyl Isononanoate Emollient 10.00 10.00 10.00

[0089] BOS - Chemspire Butyloctyl Salicylate Emollient 10.00 10.00 10.00

[0090] Dermol TDSA - Alzo Tridecyl Salicylate Acid Emollient 5.00 5.00 5.00

[0091] Volasil DM-1 - Chemsil Trisiloxane Emollient 5.00 5.00 5.00

[0092] 12 Cithrol DPHS - Croda PEG-30 Emulsifier

[0093] 3.00 3.00 3.00 Dipolyhydroxystearate

[0094] SolaStay SI - Hallstar Ethylhexyl SPF Booster

[0095] 3.00 3.00 3.00 Methoxycrylene

[0096] Tego SP13-6 - Evonik Poly C10-30 Alkyl SPF Booster

[0097] 2.00 2.00 2.00 Acrylate

[0098] DL-alpha-Tocopherol Care - Tocopheryl Acetate Skin repair

[0099] 0.50 0.50 BASF _ active

[0100] Dragosantol 100 - Symrise Skin soothing

[0101] Bisabolol 0.20 0.20 aid

[0102] D SymDiol 68T - Symrise 1,2-Hexanediol / Preservative Caprylyl Glycol / 1.00 1.00 1.00 Tropolone _

[0103] 1% Solution Chocolate FD&C Red 40, Yellow Color

[0104] 3.95 Brown Mix 485 - Pylam 6, Blue 1 Salted Skin Fragrance - Fragrance

[0105] Fragrance 0.25 Robertet

[0106] SPF 504-

[0107] Metal Oxide 6 % ZnO / Water

[0108] Exemplary embodiments of the metal oxide sunscreen formulations described herein include:

[0109] Embodiment 1: A sunscreen formulation comprising a metal oxide and an electrosteric polymeric dispersing agent, wherein the formulation is a water-in-oil emulsion, and wherein the metal oxide is present in the water phase of the water-in-oil emulsion.

[0110] Embodiment 2: The sunscreen formulation of embodiment 1, wherein the metal oxide is present in a concentration of 3 % to 20 %, from 3 % to 10 %, or from 3 % to 7 % by weight

[0111] Embodiment 3: The sunscreen formulation of any previous exemplary embodiment, wherein the metal oxide is in the form of agglomerates of primary particles, wherein the agglomerates have an average size from 50 nm to 250 nm, from 75 nm to 200 nm, or from 74 nm to 150 nm.

[0112] Embodiment 4: The sunscreen formulation of any previous exemplary embodiment, wherein the metal oxide comprises zinc oxide, titanium dioxide, cerium oxide, iron oxide, or a combination thereof.

[0113] Embodiment 5: The sunscreen formulation of any previous exemplary embodiment, wherein the metal oxide comprises zinc oxide.

[0114] 13 Embodiment 6: The sunscreen formulation of any previous exemplary embodiment, wherein the metal oxide comprises zinc oxide and titanium dioxide.

[0115] Embodiment 7: The sunscreen formulation of any previous exemplary embodiment, wherein the dispersing agent is a charged polymer comprising side chains comprising at least three carbon atoms.

[0116] Embodiment 8: The sunscreen formulation of embodiment 7, wherein the side chains that comprise branched alkyl groups with at least six carbon atoms.

[0117] Embodiment 9: The sunscreen formulation of embodiment 7 or 8, wherein the side chains further comprise at least one heteroatom that is oxygen, nitrogen, or phosphorus.

[0118] Embodiment 10: The sunscreen formulation of any previous exemplary embodiment, wherein the dispersing agent is a copolymer comprising acrylate, methacrylate, maleic acid, or maleic anhydride monomers.

[0119] Embodiment 11: The sunscreen formulation of any previous exemplary embodiment, wherein the dispersing agent comprises an acrylate / ethylhexylacrylate copolymer, acrylate / methacryloyloxyethyl phosphate copolymer, acrylate / dimethylaminoethyl methacrylate copolymer, or butyl ester of PVM / MA copolymer.

[0120] Embodiment 12: The sunscreen formulation of any previous exemplary embodiment, wherein the dispersing agent is an acrylate / ethylhexylacrylate copolymer.

[0121] Embodiment 13: The sunscreen formulation of any previous exemplary embodiment, wherein the dispersing agent is present in a concentration of 0.3 % to 2.0 %, or 0.3 % to 1.0 %, or 0.3 % to 0.7 % by weight

[0122] Embodiment 14: The sunscreen formulation of any previous exemplary embodiment, wherein the formulation has an SPF efficiency greater than 8 to 1.

[0123] Embodiment 15: The sunscreen formulation of any previous exemplary embodiment, wherein the formulation provides an SPF greater than 15.

[0124] Embodiment 16: The sunscreen formulation of any previous exemplary embodiment, wherein the metal oxide is zinc oxide, wherein the zinc oxide is present in the formulation at a concentration of from 5 % to 20 %, wherein the dispersing agent is an

[0125] 14 acrylate / ethylhexylacrylate copolymer, and wherein the acrylate / ethylhexylacrylate copolymer is present in the formulation at a concentration of from 0.5 % to 2.0 %.

[0126] It should be apparent to those skilled in the art that the foregoing is merely illustrative and not limiting, having been presented by way of example only. Numerous modifications and other embodiments are within the scope of one of ordinary skill in the art and are contemplated as falling within the scope of the invention. Although many of the examples presented herein involve specific combinations of method acts or system elements, it should be understood that those acts and those elements may be combined in other ways to accomplish the same objectives.

[0127] 15

Claims

CLAIMSWhat is claimed is:

1. A sunscreen formulation comprising a metal oxide and an electrostatic polymeric dispersing agent, wherein the formulation is a water-in-oil emulsion, and wherein the metal oxide is present in the water phase of the water-in-oil emulsion.

2. The sunscreen formulation of claim 1, wherein the metal oxide is present in a concentration of 3 % to 20 % by weight.

3. The sunscreen formulation of claim 2, wherein the metal oxide is present in a concentration of 3 % to 10 % by weight.

4. The sunscreen formulation of claim 1, wherein the metal oxide is in die form of agglomerates of primary particles, wherein the agglomerates have an average size from 50 nm to 250 nm.

5. The sunscreen formulation of claim 4, wherein the metal oxide is in the form of agglomerates of primary particles, wherein the agglomerates have an average size from 75 nm to 200 nm.

6. The sunscreen formulation of claim 1, wherein the metal oxide comprises zinc oxide, titanium dioxide, cerium oxide, or iron oxide.

7. The sunscreen formulation of claim 6, wherein the metal oxide comprises zinc oxide.

8. The sunscreen formulation of claim 6, wherein the metal oxide comprises zinc oxide and titanium dioxide.

9. The sunscreen formulation of claim 1, wherein die dispersing agent is a charged polymer comprising side chains comprising at least three carbon atoms.

10. The sunscreen formulation of claim 9, wherein die side chains comprise branched alkyl groups with at least six carbon atoms.

11. The sunscreen formulation of claim 9, wherein die side chains further comprise at least one heteroatom that is oxygen, nitrogen, or phosphorus.1612. The sunscreen formulation of claim 9, wherein the dispersing agent is a copolymer comprising acrylate, methacrylate, maleic acid, or maleic anhydride monomers.

13. The sunscreen formulation of claim 8, wherein the dispersing agent comprises an acrylate / ethylhexylacrylate copolymer, acrylate / methacryloyloxyethyl phosphate copolymer, acrylate / dimethylaminoethyl methacrylate copolymer, or butyl ester of PVM / MA copolymer.

14. The sunscreen formulation of claim 13, wherein the dispersing agent is an acrylate / ethylhexylacrylate copolymer.

15. The sunscreen formulation of claim 1, wherein die dispersing agent is present in a concentration of 0.3 % to 2.0 % by weight.

16. The sunscreen formulation of claim 15, wherein the dispersing agent is present in a concentration of 0.3 % to 1.0 % by weight.

17. The sunscreen formulation of claim 1, wherein the formulation has an SPF efficiency greater than 8 to 1.

18. The sunscreen formulation of claim 1, wherein the formulation provides an SPF greater than 15.

19. The sunscreen formulation of claim 1, wherein the metal oxide is zinc oxide, wherein the zinc oxide is present in the formulation at a concentration of from 5 % to 20 %, wherein the dispersing agent is an acrylate / ethylhexylacrylate copolymer, and wherein the acrylate / ethylhexylacrylate copolymer is present in the formulation at a concentration of from 0.5 % to 2.0 %.17

Citation Information

Patent Citations

  • Water-in-oil emulsions

    EP0559320B1

  • Mineral sunscreen compositions

    US20220387271A1

  • Sunscreen compositions including particulate sunscreen actives that exhibit boosting of sun protection factor

    WO2010093573A2

  • Organic and mineral filter hybrid sunscreen

    WO2022006408A1